Saratov JOURNAL of Medical and Scientific Research
Home

Clinical characteristics and outcomes of anemic patients with coronary artery disease after percutaneous coronary intervention (systematic review)

Year: 2023, volume 19 Issue: №4 Pages: 370-377
Heading: Cardiology Article type: Review
Authors: Simonyan M.A., Klochkov V.A., Gordeev I.A., Kalyuta T.Yu., Kiselev A.R., Gridnev V.I., Posnenkova O.M.
Organization: National Research Centre for Therapy and Preventive Medicine, Saratov State Medical University
Summary:

Objective: to explore clinical characteristics and the influence of anemic syndrome on long-term outcomes of patients with coronary artery disease underwent percutaneous coronary intervention (PCI). Review writing methodology. A systematic review was performed according to PRISMA methodology using PubMed, Google Scholar, eLibrary, CyberLeninka databases. Search depth —from 2000 to 2022. The review included 16 original studies. Conclusion. It was shown that the patients with PCI and anemia were older, predominantly male sex as compared with patients without anemic syndrome. The risk of adverse short- and long-term outcomes (myocardial infarction, stroke, major bleeding, cardiovascular and non-cardiovascular death) was significantly increased in anemic patients even with a slight decrease in hemoglobin according to WHO criteria (less than 130 g/lfor men and less than 120 g/l for women). But majority of patients were not fit with the criteria of light grade of anemia according federal clinical guidelines (hemoglobin 90-110 g/l). The influence of anemia on outcomes becomes the most significant 12 months after PCI.

Keywords: coronary heart diseases, percutaneous coronary intervention, prognosis

Bibliography:
1. Alekyan BG, Boytsov SA, Ganyukov VI, Manoshkina EM. Impact of the COVID-19 pandemic on myocardial revasculariza-tion in patients with acute coronary syndrome in the Russian Federation. Rational Pharmacotherapy in Cardiology. 2022; 18 (4): 411-9 DOI:10.20996/1819-6446 -2022-08-03
2. Erlikh AD. How "real life" treatment of patients with ST-elevation acute coronary syndrome has changed during recent several years (data from a series of the Russian RECORD Registries). Cardiology. 2018; 58 (7): 23-31. DOI:0.18087/cardio.2018.7.10140
3. Alekyan BG, Karapetyan NG, Meleshenko NN, Revish-vili ASh. Results of myocardial revascularization in patients with coronary artery disease with intermediate coronary stenosis under control of instantaneous wave-free ratio. Russian Journal of Endovascular Surgery. 2021; 8 (1): 20-6. DOI:10.24183/2 409-4080-2021 -8-1 -20-26
4. Ziankou АА, Isaev MN, Kondratyev DA, et al. Minimally invasive multivessel coronary artery bypass grafting safe and efficient: The experience of the first 500 cases. Clinical and Experimental Surgery. Petrovsky Journal. 2021; 9 (4): 20-8. DOI:10.33029/2308-1198-2021-9-4-20-28
5. Vasiliev DK, Rudenko BA, Shanoyan AS, et al. Endovas-cular myocardial revascularization in patients with multivessel coronary artery disease with chronic total occlusion and high surgical risk. Cardiovascular Therapy and Prevention. 2020; 19 (6): 2697. DOI:10.15829/1728-8 800-2020-2697
6. Bockeria LA, Berishvili II, Vakhromeeva MN, et al. Comparative analysis of results of coronary artery bypass grafting combined with transmyocardial laser revascularization versus CABG alone in patients with ischemic heart disease. Prospective controlled non-randomized study. Annals of Surgery. 2012; (4): 34-40.
7. Shevchenko YuL, Musaev IA, Borshchev GG, et al. Myocardial revascularization in elderly patients with severe myocardial insufficiency. Bulletin of the National Medical and Surgical Center N.I. Pirogov. 2020; 15 (4): 12-8 DOI:10.25881/BPNMSC.2020.22.25.002
8. Kichin VV, Sozykin AV, Yurishev AYu, et al. Long-term results of stenting patients with multivessel coronary disease and concomitant type II diabetes mellitus with Zotarolimus drug-eluting stents. Diagnostic and Interventional Radiology. 2015; 9 (1): 46-52.
9. Denisenko-Kankiya El, Chanakhchian FN, Vasilenko El, et al. Comparative analysis of myocardial perfusion scintigraphy data in patients with coronary artery disease of varying severity. Cardiology Bulletin. 2019; 14 (4): 59-65.DOI:10.36396/MS. 2019.15.4.008.
10. Tsujita К, Nikolsky Е, Lansky AJ, et al. Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrom-botic therapy (from the HORIZONS-AMItrial). Am J Cardiol. 2010; 105(10): 1385-94. DOI: 10.1016/j.amjcard.2010.01.001
11. Kitai Y, Ozasa N, Morimoto T, et al. Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention. Int J Cardiol. 2013; (168): 5221-8. DOI:10.1016/j.ijcard.2013.08.029
12. Erlikh AD, Gratsianskyi NA. Treatment specifics and clinical outcomes in patients with acute coronary syndrome and anaemia: RECORD registry results. Russian Journal of Cardiology. 2012; (5): 12-6.
13. Denisova EYu, Zheleznyakova NA, Kalyuta TYu, et al. Influence of anemia on indicators of quality of life in patients with pathology of the cardiovascular system. Therapy. 2021; (3): 68-7.DOI:10.18565/therapy.2021.3.68-7
14. Morozova VD, Glushakov IA, Kalyuta TYu, et al. Anemia in acute coronary syndrome: Prognostic value and treatment. Therapy. 2021; (3): 74-9. DOI: 10.18565/therapy.2021.3.74-79
15. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014; (35): 2541-619. DOI:10.1093/eurheartj/ehu278
16. Huynh R, Huyn K, D'Souza M, et al. Outcomes of anemic patients presenting with acute coronary syndrome: An analysis of the Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events. Clin Cardiol. 2019; 42 (9): 791-6. DOI:10.1002/clc.23219
17. Rathod KS, Jones DA, Rathod VS, et al. A Prognostic impact of anemia on patients with ST-elevation myocardial infarction treated by primary PCI. Coron Artery Dis. 2014; 25 (1): 52-9. DOI:10.1097/MCA.0000000000000038
18. Zykov MV, Dyachenko NV, Trubnikova OA, et al. Comorbidity and gender of patients in assessing the risk of death in hospital after emergency percutaneous coronary intervention. Cardiology. 2020; 60 (9): 38-45.DOI:10.18087/cardio.2020.9.n1166
19. Mansurova JA, Karazhanova LK. Independent predictors of adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention during hospitalization. Kardiologiia. 2018; 58 (12): 22-9. DOI:10.18087/cardio.2018.12.10205
20. McKechnie RS, Smith D, Montoye C, et al. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation. 2004; 110 (3): 271-7. DOI:10.1161/01 .CIR.0000134964.01697.C7
21. Matsue Y, Matsumura A, Abe M, et al. Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients. Heart Vessels. 2013; 28 (1): 19-26. DOI:10.1007/s00380-011-0209-2
22. Kim T-H, Koh Y-S, Chang K, et al. Improved anemia is associated with favorable long-term clinical outcomes in patients undergoing PCI. Coronary Artery Disease. 2012; 23 (6): 391-9. DOI:10.1097/mca.0b013e3283564869
23. AN ZA, Poludasu S, Qureshi YH, et al. Impact of major bleeding on long-term mortality in anemic versus nonanemic patients undergoing percutaneous coronary intervention using bivalirudin. Am J Cardiol. 2014; 113(9): 1481-6. DOI:10.1016/j. amjcard.2014.01.427
24. Wang H, Yang Y, Ma L, et al. Impact of anemia and dual antiplatelet therapy on mortality in patients undergoing percutaneous coronary intervention with drug-eluting stents. Sci Rep. 2015; (5): 17213. DOI: 10.1038/srep17213
25. Stahli BE, Gebhard C, Gick M, et al. Impact of anemia on long-term outcomes after percutaneous coronary intervention for chronic total occlusion. Catheter Cardiovasc Interv. 2018; 91 (2): 226-33. DOI:10.1002/ccd.27412
26. Yazji K, Abdul F, Elangovan S, et al. Baseline anemia in patients undergoing percutaneous coronary intervention after an acute coronary syndrome-A paradox of high bleeding risk, high ischemic risk, and complex coronary disease. J Interv Cardiol. 2017; 30 (5): 491-9. DOI:10.1111/joic.12406
27. Al-Hijji MA, Gulati R, Lennon RJ, et al. Outcomes of percutaneous coronary interventions in patients with anemia presenting with acute coronary syndrome. Mayo Clinic Proceedings. 2018; 93 (10): 1448-61. DOI:10.1016/j.mayocp.2018.03.030
28. Jiang L, Gao Z, Song Y, et al. Impact of anemia on percutaneous coronary intervention in Chinese patients: A large single center data. J Interv Cardiol. 2018; 1-8. DOI: 10.1111/joic. 12570.
29. Park JY, Choi BG, Rha S-W, Kang TS. Five-year outcomes in patients with anemia on admission undergoing a coronary intervention for acute myocardial infarction in Koreans. Coronary Artery Disease. 2018; 29 (8): 647-51. DOI:10.1097/MCA. 0000000000000657
30. Cilia L, Sharbaugh M, Marroquin O, et al. Impact of chronic kidney disease and anemia on outcomes following percutaneous coronary revascularization. Am J Cardiol. 2019; 124 (6): 851-6. DOI:10.1016/j.amjcard.2019.06.001
31. Wester A, Attar R, Mohammad MA, etal. Impact of baseline anemia in patients with acute coronary syndromes undergoing percutaneous coronary intervention: A prespecified analysis from the VALIDATE-SWEDEHEART trial. J Am Heart Assoc. 2019; 8 (16): e012741. DOI:10.1161/jaha. 119.012741
32. Kani K, Sakakura K, Taniguchi Y, et al. Association of baseline anemia with mid-term clinical outcomes in patients who underwent trans-radial primary percutaneous coronary intervention. Int Heart J. 2021; 62 (2): 256-63. DOI:10.1016/10.1536/ihj. 20-536
33. Marti D, Carballeira D, Morales MJ, et al. Impact of anemia on the risk of bleeding following percutaneous coronary interventions in patients >75 years of age. Am J Cardiol. 2020; 125 (8): 1142-7. DOI:10.1016/j.amjcard.2020.01.010
34. Hu H, Wang S, Tang G, et al. Impact of anemia on in-stent restenosis after percutaneous coronary intervention. ВМС CardiovascDisord.2021;21 (1):548. DOI:10.1186/s12872-021-02355-1
35. Takeuchi M, Dohi T, Takahashi N, et al. The prognostic implications of chronic kidney disease and anemia on long-term outcomes in patients undergoing percutaneous coronary intervention. Heart Vessels. 2021; 36 (8): 1117-24. DOI:10.1007/s00 380-021-01794-2
36. Makarova AN. The distribution of anemia and iron deficiency of patients with ishemic heart disease. Medical Science and Education of the Urals. 2009; 3 (59): 104-5.

AttachmentSize
2023_04_370-377.pdf465.14 KB
All articles of the authors: Gordeev I.A., Gridnev V.I., Kaluta T.Yu., Kiselev A.R., Klochkov V.A., Posnenkova O.M., Simonyan M.A.

No votes yet